Gériatrie [Review in geriatric medicine 2011].
| Data(s) |
2012
|
|---|---|
| Resumo |
In 2011, new tools to evaluate life expectancy are available. Controversy about PSA-based screening for prostate cancer is still going on, with new data from the US Preventive services task force. A brief behavioral treatment for insomnia can be efficient and durable. Gliptines are be useful to avoid treatment-induced hypoglycemia in diabetic patients. New Alzheimer diagnostic criteria, including biomarkers, have been published. |
| Identificador |
http://serval.unil.ch/?id=serval:BIB_B96860CA7DA0 isbn:1660-9379 (Print) pmid:22303735 |
| Idioma(s) |
fr |
| Fonte |
Revue Médicale Suisse, vol. 8, no. 323, pp. 23-27 |
| Palavras-Chave | #Aging; Alzheimer Disease/diagnosis; Behavior Therapy; Diabetes Mellitus, Type 2/drug therapy; Dipeptidyl-Peptidase IV Inhibitors/administration & dosage; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Early Detection of Cancer; Geriatrics/trends; Humans; Hypoglycemic Agents/administration & dosage; Hypoglycemic Agents/adverse effects; Life Expectancy; Male; Mass Screening; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood; Prostatic Neoplasms/diagnosis; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders/therapy; Tumor Markers, Biological/blood |
| Tipo |
info:eu-repo/semantics/review article |
